Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design StudyMichael Wang, M. Lia Palomba, Tanya Siddiqi et al.|Journal of Clinical Oncology|2023Cited by 94